Home  |  About JAPTR |  Editorial board  |  Search |  Ahead of print  |  Current issue  |  Archives |  Submit article  |  Instructions  |  Subscribe  |  Advertise  |  Contacts  |Login 
Users Online: 37   Home Print this page Email this page Small font sizeDefault font sizeIncrease font size

 Table of Contents  
Year : 2010  |  Volume : 1  |  Issue : 4  |  Page : 415-418  

Analgesic and antipyretic activities of Momordica charantia linn. fruits

Shree Leuva Patel Trust Pharmacy Mahila College, Amreli, Gujarat, India

Date of Web Publication3-Feb-2011

Correspondence Address:
Roshan Patel
Department of Pharmacognosy, Shree Leuva Patel Trust Pharmacy Mahila College, Patel Sankul, Chakkargadh Road, Amreli - 365 601, Gujarat
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0110-5558.76441

Rights and Permissions

Plant Momordica charantia Linn. belongs to family Cucurbitaceae. It is known as bitter gourd in English and karela in Hindi. Earlier claims show that the plant is used in stomachic ailments as a carminative tonic; as an antipyretic and antidiabetic agent; and in rheumatoid arthritis and gout. The fruit has been claimed to contain charantin, steroidal saponin, momordium, carbohydrates, mineral matters, ascorbic acid, alkaloids, glucosides, etc. The ethanolic extract of the fruit showed the presence of alkaloids, tannins, glycosides, steroids, proteins, and carbohydrates. The present study was carried out using acetic acid-induced writhing and tail-immersion tests in mice, while yeast-induced pyrexia in rats. The ethanolic extracts (250 and 500 mg/kg, po.) showed an analgesic and antipyretic effect, which was significantly higher than that in the control rats. The observed pharmacological activities provide the scientific basis to support traditional claims as well as explore some new and promising leads.

Keywords: Analgesic, antipyretic, Momordica charantia

How to cite this article:
Patel R, Mahobia N, Upwar N, Waseem N, Talaviya H, Patel Z. Analgesic and antipyretic activities of Momordica charantia linn. fruits. J Adv Pharm Technol Res 2010;1:415-8

How to cite this URL:
Patel R, Mahobia N, Upwar N, Waseem N, Talaviya H, Patel Z. Analgesic and antipyretic activities of Momordica charantia linn. fruits. J Adv Pharm Technol Res [serial online] 2010 [cited 2023 Feb 8];1:415-8. Available from: https://www.japtr.org/text.asp?2010/1/4/415/76441

   Introduction Top

Pain is an ill-defined, unpleasant, sensation usually evoked by an external or internal noxious stimulus. It is a warning signal and primarily protective in nature, but causes discomfort. Analgesics are the drugs that selectively relieve pain by acting on the CNS (central nervous system) or on peripheral pain mechanisms, without significantly altering consciousness. Plant Momordica charantia Linn., known as bitter gourd in English, belongs to family Cucurbitaceae. It is cultivated throughout India, Malaya, China, Tropical Africa, and America. Earlier claims showed that its bitter fruits have carminative, aphrodisiac, and anthelmintic properties, and are used in syphilis, rheumatism, troubles of spleen, and ophthalmia. It is also useful in piles, leprosy, jaundice, and also used as a vermifuge. [1] Upon a literature review, it was found that the plant contains moisture (83.2%), proteins (2.9%), fat (1.0%), carbon (9.8%), fibers (1.7%), mineral matters (1.4%), calcium, phosphorus, iron, carotene, thiamine, nicotinic acid, riboflavin, ascorbic acid (88 mg/100 g), copper, and potassium. [2] Charantin, β-sitosterol-glucoside, stigmast-5, 25-dien-3 β-O-glucoside, stigmast-7,25-dien-3 β-ol, and stigmast-7, 22,25-trien-3 β-ol are isolated from the fruit.[3] Many pharmacological properties have been reported including antioxidant, [4] adipogenesis-reducing, [5] antilipolytic, [6] hypoglycemic, [7] antidiabetic, [8] anticancer, [9] antifertility, [10] antigenotoxic, [11] anthelmintic, [12] antimicrobial, [13] antiviral, [14] and hepatoprotective activity. [15] However, there are no reports to our knowledge on its analgesic and antipyretic activities. Hence, the present study was undertaken to investigate the analgesic and antipyretic potential of the ethanolic and aqueous fruit extract of M. charantia Linn. in experimental animal models.

   Materials and Methods Top

All the ingredients and chemicals were of analytical grade and purchased from Loba Chemie Pvt. Ltd., Mumbai.

Collection of Plant Materials

A healthy fruit was purchased from a medicinal plant supplier, Hakimm's Brother, Savarkundala (Gujarat) in the month of July 2009. It was identified and authenticated by Dr. A. S. Reddy, taxonomist, Bioscience Department, S. P. University, Vallabh Vidyanagar, Gujarat, India.

Preparation of the Plant Extract

The powdered fruit was extracted with ethanol by the Soxhlet apparatus. The solvent was concentrated by evaporating ethanol using a rotary evaporator. [16] The M. charantia ethanol extract (MC-EE) was further concentrated by allowing it to stand overnight in an oven at 30΀C.

Phytochemical Tests

The MC-EE was subjected to preliminary, qualitative, phytochemical investigation. [17]

Animals Used

Wistar rats, weighing 200-220 g, and Swiss albino mice, weighing 18-25 g, of either sex were procured from the animal house of the Shree Leuva Patel Trust Pharmacy Mahila College, Amreli, Gujarat, India. All the animals were kept in standard polypropylene cages under standard conditions: temperature (24΁1΀C), relative humidity (45-55%), and a 12:12 light:dark cycle. The animals were fed a standard rodent diet, and water was given ad libitum. The animals were allowed to acclimatize to laboratory conditions 48 h before the start of the experiment. The experimental protocol is duly approved by the institutional ethical committee (reg. no. 949/a/06/CPCSEA).

Acute Toxicity Study

Six Wistar rats (200-220 g) and six albino mice (18-25 g) of either sex were dosed with MC-EE extracts in different concentrations and were observed for any symptoms of toxicity for 48 h as per guideline no. 425 (OECD 2001), and LD 50 was estimated to be >5000 mg/kg. Based on the results obtained from this study, the doses of further pharmacological studies were fixed to be 250 and 500 mg/kg. [18]

Analgesic Activities

Acetic acid-induced writhing

Mice were divided into four groups each consisting of six mice. They were starved for 18 h. The treatment regimen was as follows:

  1. Group I (control): Vehicle (3 ml/kg, po.), 1% suspension of Tween-80
  2. Group II (standard): Aspirin (150 mg/kg, po.)
  3. Group III (test 1): Ethanolic fruit extract (500 mg/kg, po.)
  4. Group IV (test 2): Ethanolic fruit extract (250 mg/kg, po.).

After half an hour, all mice received a 0.7% aqueous solution of acetic acid 10 mg/kg, ip., and writhings were counted for 10 min after the acid injection. [19]

Acetic acid-induced writhing test

Tail-immersion method

Mice were divided into four groups each consisting of six mice. The treatment regimen was as follows:

  1. Group I (control): Vehicle (3 ml/kg, po.), 1% suspension of Tween-80
  2. Group II (standard): Pentazocine (30 mg/kg, po.)
  3. Group III (test 1): Ethanolic fruit extract (500 mg/kg, po.)
  4. Group IV (test 2): Ethanolic fruit extract (250 mg/kg, po.).

The distal part of the tails of the animals was immersed in hot water maintained at 55.0±1.0΀C. The time taken to withdraw the tail was noted as the reaction time. A cut-off time of 10 s was maintained at 55΀C to prevent tissue damage. The reaction time was checked at 0, 15, 30, 45 and 60 min, respectively, after treatment. [19]

Antipyretic Activity

Rats were divided into four groups each consisting of six rats. The test was performed in rats by injecting 10 ml/kg sc. of the 15% aqueous solution of Brewer's yeast to induce pyrexia. The rectal temperature of each animal was taken before and 24 h after the yeast injection using a digital clinical thermometer. Animals that did not show a minimum increase of 0.7΀C in the temperature 24 h after the yeast injection were discarded. The selected animals were divided into four groups and treated as follows:

  1. Group I (control): Vehicle (3 ml/kg, po.), 1% suspension of Tween-80
  2. Group II (standard): Paracetamol (20 mg/kg, ip.)
  3. Group III (test 1): Ethanolic fruit extract (500 mg/kg, po.)
  4. Group IV (test 2): Ethanolic fruit extract (250 mg/kg, po.).

The rectal temperature of each animal was again recorded at 0.5, 1, 1.5, and 2 h after treatment. [20]

Statistical Analysis

Data were subjected to statistical analysis using ANOVA, and statistical comparison was done using the Tukey-Kramer multiple comparison test. Values of P<0.01 were considered statistically significant.

   Results Top

Phytochemical Tests

The crude extract was found to be positive for the presence of alkaloids, tannins, glycosides, steroids, proteins, and carbohydrates.

Acute Toxicity Study

After 48 h of the study with different concentrations of the extract, the LD 50 was estimated to be >5000 mg/kg.

Effect on acetic acid writhing

The ethanolic extracts (500 and 250 mg/kg, po.) significantly reduced the acetic acid-induced writhing by 59.99% and 51.22%, respectively [Table 1].
Table 1 :Effect of ethanolic extracts of the Momordica charantia fruit in acetic acid-induced writhing in mice

Click here to view

Effect on the tail-immersion test

Ethanolic extracts (500 and 250 mg/kg, po.) induced significant protection [Table 2] in rats in tail-immersion tests, with the ethanolic extracts (500 mg/kg) being more active compared to the standard drug pentazocine (30 mg/kg, po.).
Table 2 :Effect of ethanolic and aqueous extracts of the Plectranthus amboinicus leaf on tail-immersion tests in mice

Click here to view

Antipyretic Effect

Both the extracts showed a marked antipyretic effect [Table 3] by causing a reduction in yeast-induced fever. The ethanolic extract (500 mg/kg) showed the effect to the same degree as paracetamol (20 mg/kg, ip.).
Table 3 :Effect of ethanolic and aqueous extracts of the Plectranthus amboinicus leaf on yeast-induced pyrexia in rats

Click here to view

   Discussion Top

Several experimentally induced laboratory models were employed in evaluating the analgesic and antipyretic activities of ethanolic extracts of M. charantia. It is necessary to apply tests which differ with respect to stimulus quality, intensity, and duration, to obtain as complete a picture as possible of the analgesic properties of a substance using behavioural nociceptive tests. The results obtained showed that the ethanolic extracts possess a significant analgesic effect on the various pain models used. A significant inhibitory effect was shown by both the extracts in the writhing test (a test useful for evaluating mild analgesic, nonsteroidal, anti-inflammatory agents). This suggests that the analgesic effect of the extract may be peripherally mediated. The extracts also showed a significant effect in the tail-immersion tests (centrally acting analgesic drugs elevate the pain threshold of animals toward heat and pressure). The effect of the extracts on this pain model indicates that it might be centrally acting. [20]

The extract caused a better hypothermal activity against yeast-induced pyrexia in rats. The subcutaneous injection of yeast induces pyrexia by increasing the synthesis of prostaglandin and is used to screen agents for an antipyretic effect. [19]

The analgesic and antipyretic activity of M. charantia Linn. may be due to the individual or combined action of bioactive constituents present in it. The findings will be helpful for further phytochemical and pharmacodynamic investigations to find the active constituents responsible for the activity, which may explore some new and promising leads.

   Acknowledgment Top

The author's grateful to the Principal and Management, Shree Leuva Patel Trust Pharmacy Mahila College, Amreli, for extending laboratory competence and for their material support.

   References Top

1.Kirtikar KR, Basu BD. Indian Medicinal Plants. 2 nd ed., Vol. 2. Dehradun: International Book Distributors; 2006. p. 1130.  Back to cited text no. 1
2.Anonymous. The Wealth of India: A Dictionary of Indian Raw Materials and Industrial products. Vol. 6: L-M. New Delhi: C.S.I.R.; 1998. p. 408-10.  Back to cited text no. 2
3.Rastogi RP, Mehrotra BN. Compendium of Indian Medicinal Plants. Vol. 1. (1960-69), Lucknow: CDRI and New Delhi: NISCIR; 2004. p. 278.   Back to cited text no. 3
4.Budrat P, Shotipruk A. Extraction of phenolic compounds from fruits of bitter melon (Momordica charantia) with subcritical water extraction and antioxidant activities of these extracts. Chiang Mai J Sci 2008;35:123-30.  Back to cited text no. 4
5.Nerurkar PV, Lee YK, Nerurkar VR. Momordica charantia (bitter melon) inhibits primary human adipocyte differentiation by modulating adipogenic genes. BMC Complement Altern Med 2010;10:1-10.  Back to cited text no. 5
6.Wong CM, Ng TB, Yeung HW. Screening of Trichosanthes kirilowii, Momordica charantia and Cucurbita maxima (family Cucurbitaceae) for compounds with antilipolytic activity. J Ethnopharmacol 1985;13:313-21.   Back to cited text no. 6
7.Tongia A, Tongia SK, Dave M. Phytochemical determination and extraction of Momordica charantia fruit and its hypoglycaemic potentiation of oral hypoglycaemic drugs in Diabetes mellitus (NIDDM). Indian J Physiol Pharmacol 2004;48:241-4.  Back to cited text no. 7
8.Raza H, Ahmed I, John A, Sharma AK. Modulation of xenobiotic metabolism and oxidative stress in chronic streptozotocin-induced diabetic rats fed with Momordica charantia fruit extract. J Biochem Mol Toxicol. 2000;14:131-9.   Back to cited text no. 8
9.Cunnick JE, Sakamoto K, Chapes SK, Fortner GW, Takemoto DJ. Induction of tumor cytotoxic immune cells using a protein from the bitter melon (Momordica charantia). Cell Immunol 1990;126:278-89.  Back to cited text no. 9
10.Ng TB, Tam PP, Hon WK, Choi HL, Yeung HW. Effects of momorcharins on ovarian response to gonadotropininduced superovulation in mice. Int J Fertil 1998;33:123-8.  Back to cited text no. 10
11.Balboa JG, LimSylianco CY. Antigenotoxic effects of drug preparations Akapulko and Ampalaya. Philipp J Sci 1992;121:399.  Back to cited text no. 11
12.Lal J, Chandra S, Raviprakash V, Sabir M. In vitro anthelmintic action of some indigenous medicinal plants on Ascaridia galli worms. Indian J Physiol Pharmacol 1976;20:64-8.  Back to cited text no. 12
13.Sankaranarayanan J, Jolly CI. Phytochemical, antibacterial, and pharmacological investigations on Momordica charantia Linn. Emblica officinalis Gaertn. and Curcuma longa Linn. Indian J Pharm Sci 1993;55:6.  Back to cited text no. 13
14.Bourinbaiar AS, LeeHuang S. The activity of plantderived antiretroviral proteins MAP30 and GAP31 against herpes simplex virus infection in vitro. Biochem Biophys Res Commun 1996;219:923-9.   Back to cited text no. 14
15.Kusamran WR, Ratanavila A, Tepsuwan A. Effects of neem flowers, Thai and Chinese bitter gourd fruits and sweet basil leaves on hepatic monooxygenases and glutathione S-transferase activities, and in vitro metabolic activation of chemical carcinogens in rats. Food Chem Toxicol 1998;36:475-84.  Back to cited text no. 15
16.Kokate CK. Practical Pharmacognosy. New Delhi: Vallabh Prakashan; 1999. p. 149-56.  Back to cited text no. 16
17.Khandelwal KR. Practical Pharmacognosy: Techniques and Experiments. 17 th ed. Pune: Nirali Prakashan; 2007. p. 149-56.  Back to cited text no. 17
18.Anonymous. Organization for Economic Co-operation and Development. Guidance Document on Acute Oral Toxicity Testing. Environment Directorate, OECD, Peris; 2001. p. 1-24.   Back to cited text no. 18
19.Bose A, Mondal S, Gupta JK, Ghosh T, Dash GK, Si S. Analgesic, anti-inflammatory and antipyretic activities of the ethanolic extract and its fractions of Cleome rutidosperma. Fitoterapia 2007;78:515-20.  Back to cited text no. 19
20.Ghule BV, Murugananthan G, Yeole PG. Analgesic and antipyretic effects of Capparis zeylanica leaves. Fitoterapia 2007;78:365-9.  Back to cited text no. 20


  [Table 1], [Table 2], [Table 3]

This article has been cited by
1 Traditional perinatal plant knowledge in Sub-Saharan Africa: Comprehensive compilation and secondary analysis
Lindiwe Sibeko, Timothy Johns, Bi-sek Hsiao
South African Journal of Botany. 2023; 154: 120
[Pubmed] | [DOI]
2 Anti-Aging Effect of Momordica charantia L. on d-Galactose-Induced Subacute Aging in Mice by Activating PI3K/AKT Signaling Pathway
Dongxue Wang, Enhui Wang, Ying Li, Yaran Teng, Hui Li, Lili Jiao, Wei Wu
Molecules. 2022; 27(14): 4502
[Pubmed] | [DOI]
3 Toxicity and teratogenicity evaluation of ethanolic extract from Momordica charantia fruit using zebrafish (Danio rerio) embryo model
Vikneswari Perumal, Alfi Khatib, Qamar Uddin Ahmed, Bisha Fathamah Uzir, Suganya Murugesu, Riesta Primaharinastiti, Hesham El-Seedi, Jinap Selamat
International Food Research Journal. 2022; 29(3): 531
[Pubmed] | [DOI]
4 Therapeutic Potential and Pharmaceutical Applications of Cucurbita
Rishabha Malviya, Akanksha Sharma
Current Nutrition & Food Science. 2021; 17(4): 363
[Pubmed] | [DOI]
5 Physicochemical and Functional Characterization of Newly Designed Biopolymeric-Based Encapsulates with Probiotic Culture and Charantin
Awa Fanny Massounga Bora, Xiaodong Li, Lu Liu
Foods. 2021; 10(11): 2677
[Pubmed] | [DOI]
6 A simple, cost-effective, and rapid separation process for the isolation of anticoagulant active fraction from the fruit extract of Momordica charantia : Characterization of bioactive components and anticoagulant mechanism of active fraction in a mouse model
Debananda Gogoi,Shambhavi Jha,Pronobesh Chattopadhyay,Ashis K. Mukherjee
Journal of Separation Science. 2020;
[Pubmed] | [DOI]
7 An iron–carboxylate-based metal–organic framework for Furosemide loading and release
Yanita Devi,Ignatius Ang,Felycia Edi Soetaredjo,Shella Permatasari Santoso,Wenny Irawaty,Maria Yuliana,Artik Elisa Angkawijaya,Sandy Budi Hartono,Phuong Lan Tran-Nguyen,Suryadi Ismadji,Yi-Hsu Ju
Journal of Materials Science. 2020;
[Pubmed] | [DOI]
8 The chloroplast genome sequence of Momordica charantia L. (bitter gourd)
Sadia Rasheed,Sahar Zaidi,M. Kamran Azim
Gene Reports. 2020; : 100963
[Pubmed] | [DOI]
9 Phytomedicinal relevance of South African Cucurbitaceae species and their safety assessment: A review
Aitebiremen Gift Omokhua-Uyi,Johannes Van Staden
Journal of Ethnopharmacology. 2020; : 112967
[Pubmed] | [DOI]
10 Utilization of a Single Experimental Design for the Optimization of Furosemide Modified-Release Tablet Formulations
Marilena Vlachou,Angeliki Siamidi,Yannis Dotsikas
Current Drug Delivery. 2019; 16(10): 931
[Pubmed] | [DOI]
11 The effects of Momordica charantia (bitter melon) supplementation in patients with primary knee osteoarthritis: A single-blinded, randomized controlled trial
Lim Soo May,Zulkefli Sanip,Amran Ahmed Shokri,Azidah Abdul Kadir,Md Rizman Md Lazin
Complementary Therapies in Clinical Practice. 2018; 32: 181
[Pubmed] | [DOI]
12 Medicinal Plants Used in the Treatment of Mental and Neurological Disorders in Ghana
Patrick Amoateng,Emmanuel Quansah,Thomas K. Karikari,Alex Asase,Dorcas Osei-Safo,Kennedy Kwami Edem Kukuia,Isaac Kingsley Amponsah,Alexander K. Nyarko
Evidence-Based Complementary and Alternative Medicine. 2018; 2018: 1
[Pubmed] | [DOI]
13 Recent Advances in Momordica charantia: Functional Components and Biological Activities
Shuo Jia,Mingyue Shen,Fan Zhang,Jianhua Xie
International Journal of Molecular Sciences. 2017; 18(12): 2555
[Pubmed] | [DOI]
14 Anti-diabetic effects of natural products an overview of therapeutic strategies
Jiyoung Park,Hyeung-Jin Jang
Molecular & Cellular Toxicology. 2017; 13(1): 1
[Pubmed] | [DOI]
15 Momordica charantia Linn. (Cucurbitaceae): Review on Phytochemistry and Pharmacology
Javed Ahamad,Saima Amin,Showkat R. Mir
Research Journal of Phytochemistry. 2017; 11(2): 53
[Pubmed] | [DOI]
16 Methanol Extract of Bitter Melon Alleviates UVB-Induced MMPs Expression via MAP Kinase and AP-1 Signaling in Human Dermal Fibroblastsin vitro
Hyun Ji Lee,Eunson Hwang,Bom Park,Mengyang Zhang,Zheng-wang Sun,Do-Gyeong Lee,Sang-Yong Park,Tae Hoo Yi
Phytotherapy Research. 2016;
[Pubmed] | [DOI]
17 Bitter melon: a panacea for inflammation and cancer
Prasad R. Dandawate,Dharmalingam Subramaniam,Subhash B. Padhye,Shrikant Anant
Chinese Journal of Natural Medicines. 2016; 14(2): 81
[Pubmed] | [DOI]
18 A Review on Salient Pharmacological Features of Momordica charantia
Aparna Upadhyay,Pooja Agrahari,D.K. Singh
International Journal of Pharmacology. 2015; 11(5): 405
[Pubmed] | [DOI]
19 Development of an antidiabetic formulation (ADJ6) and its inhibitory activity against a-amylase and a-glucosidase
Anand Duraiswamy,Devanand Shanmugasundaram,Changam Sheela Sasikumar,Sanjay M. Cherian,Kotturathu Mammen Cherian
Journal of Traditional and Complementary Medicine. 2015;
[Pubmed] | [DOI]
20 Differential anti-diabetic effects and mechanism of action of charantin-rich extract of Taiwanese Momordica charantia between type 1 and type 2 diabetic mice
Hsien-Yi Wang,Wei-Chih Kan,Tain-Junn Cheng,Sung-Hsun Yu,Liang-Hao Chang,Jiunn-Jye Chuu
Food and Chemical Toxicology. 2014;
[Pubmed] | [DOI]
21 Evaluation of Momordica charantia L. Fruit Extract for Analgesic and Anti-inflammatory activities using in vivo Assay
M. Ullah,Mir Showkat,Nazim Uddin Ahme,Saiful Islam,Nurul Absar
Research Journal of Medicinal Plant. 2012; 6(3): 236
[Pubmed] | [DOI]
Trivedi Rashmi V, Wadher Kamlesh J, Taksande Jayashri B, Umekar Milind J
International Journal of Research in Ayurveda and Pharmacy. 2011; 2(2): 443-447


    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

  In this article
    Materials and Me...
    Article Tables

 Article Access Statistics
    PDF Downloaded837    
    Comments [Add]    
    Cited by others 22    

Recommend this journal